Asr Vermogensbeheer N.V. Vertex Pharmaceuticals Inc Transaction History
Asr Vermogensbeheer N.V.
- $8.24 Trillion
- Q3 2025
A detailed history of Asr Vermogensbeheer N.V. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Asr Vermogensbeheer N.V. holds 26,294 shares of VRTX stock, worth $10.8 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
26,294
Previous 26,419
0.47%
Holding current value
$10.8 Million
Previous $11.8 Billion
12.45%
% of portfolio
0.12%
Previous 0.15%
Shares
3 transactions
Others Institutions Holding VRTX
# of Institutions
1,786Shares Held
235MCall Options Held
1.96MPut Options Held
1.14M-
Capital World Investors Los Angeles, CA28.7MShares$11.8 Billion1.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.2MShares$9.92 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.73 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.1MShares$6.6 Billion1.5% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.82 Billion0.2% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $105B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...